:::

詳目顯示

回上一頁
題名:臨床使用Atorvastatin需加強適當性及安全性評估
書刊名:臺灣臨床藥學雜誌
作者:黃婉綾蘇富敏李冠廷黃耀斌張榮叁
作者(外文):Huang, Wan-lingSu, Fu-minLee, Kuan-tingHuang, Yaw-binChang, Jung-san
出版日期:2013
卷期:21:4
頁次:頁299-312
主題關鍵詞:適當性安全性交互作用AtorvastatinAppropriatenessSafetyDrug-drug interactions
原始連結:連回原系統網址new window
相關次數:
  • 被引用次數被引用次數:期刊(0) 博士論文(0) 專書(0) 專書論文(0)
  • 排除自我引用排除自我引用:0
  • 共同引用共同引用:2
  • 點閱點閱:4
期刊論文
1.Jellinger, P. S.、Smith, D. A.、Mehta, A. E.、Ganda, 0.、Handelsman, Y.、Rodbard, H. W.(2012)。American association of clinical endocrinologists ‘ guidelines for management of dyslipidemia and prevention of atherosclerosis。Endocr Pract,18,269-293。  new window
2.Poli, A.(2007)。Atorvastatin: pharmacological characteristics and lipid-lowering effects。Drugs,67(1),3-15。  new window
3.Area, M.(2007)。Atorvastatin: a safety and tolerability profile。Drugs,67,63-69。  new window
4.Navarro, V. J.、Senior, J. R.(2006)。Drug-related hepatotoxicity。N Engl J Med,354,731-739。  new window
5.Bellosta, S.、Paoletti, R.、Corsini, A.(2004)。Safety of statins: focus on clinical pharmacokinetics and drug interactions。Circulation,109,11150-11157。  new window
6.Gibbs, M. A.、Hosea, N. A.(2003)。Factors affecting the clinical development of cytochrome P450 3A substrates。Clin Pharmacokinet,42,969-984。  new window
7.Ahmadizar, F.、Soleymani, F.、Abdollahi, M.(2011)。Study of drug-drug interactions in prescriptions of general practitioners and specialists in Iran 2007-2009。Iran J Pharm Res,10,921-931。  new window
8.Reiner, Z.、Catapano, A. L.、De Backer, G.、Graham, I.、Taskinen, M. R.、Wiklund, O.、Wood D.(2011)。ESC/EAS Guidelines for the management of dyslipidaemias: the task force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)。EurHeart J,32(14),1769-1818。  new window
9.Bays, H.(2006)。Statin safety: an overview and assessment of the data--2005。Am J Cardiol,97,6-26。  new window
10.許郁笙、沈玫秋、李春璟、蘇淑薰(20110300)。電腦醫囑系統中藥物交互作用之篩選與用藥品質之相關性評估。臺灣臨床藥學雜誌,19(1),1-10。new window  延伸查詢new window
11.顏瑜萱、陳香吟、李友專、龍安靖、邱文達(20041200)。電腦支援系統協助用藥安全防護網的建立。醫務管理期刊,5(4),495-514。new window  延伸查詢new window
12.Scott, M.、Grundy, James, I.、Cleeman, C.、Noel, B. M.、Brewer, H. B. Jr, Luther, T. C.、Donald, B. H.、Richard C. P.、Sidney C.、Neil, J. S.,(2004)。Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines。Circulation,110,227-239。  new window
圖書
1.林秀娟、丁予安、何橈通、宋育民(2003)。高血脂防治手冊--國人血脂異常診療及預防指引。臺北:行政院衛生署國民健康局。  延伸查詢new window
2.蕭美玲、邱淑媞、徐瑞祥、陳姿伶、胡文琳(2011)。2007年臺灣地區高血壓、高血糖、高血脂之追蹤調查研究。臺北:行政院衛生署國民健康局。  延伸查詢new window
3.Dixon, W. J.、Massey, F. J.(1957)。Introduction to statistical analysis。New York:McGraw-Hill。  new window
其他
1.行政院衛生署(20120620)。國人十大死因統計資料,http://www.doh.gov. tw/CHT2006/index_populace.aspx。  延伸查詢new window
2.中央健康保險局(20120529)。健保財務及業務監理指標執行成果報告,http://www.doh.gov.tw/ufile/doc/1010928-%E8%B2%A1%E5%8B%99%E5%8F%8A% E6%A5%AD%E5%8B%99%E7%9B%A3%E 7%90%86%E6%8C%87%E6%A8%99.pdf。  new window
 
 
 
 
第一頁 上一頁 下一頁 最後一頁 top
QR Code
QRCODE